Cargando…

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

BACKGROUND: Patient-related factors such as concern about cancer are believed to influence both men’s decisions to undergo prostate specific antigen (PSA) testing and to have definitive treatment if diagnosed with low risk prostate cancer (PCa). The potential link between screening frequency and cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beckmann, Kerri, Kinsella, Netty, Olsson, Henrik, Wallerstedt Lantz, Anna, Nordstrom, Tobias, Aly, Markus, Adolfsson, Jan, Eklund, Martin, Van Hemelrijck, Mieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683376/ https://www.ncbi.nlm.nih.gov/pubmed/31383015 http://dx.doi.org/10.1186/s12894-019-0502-4

Ejemplares similares

Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Developing a consensus statement for psychosocial support in active surveillance for prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2022)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
por: Björnebo, Lars, et al.
Publicado: (2020)

Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
por: Kinsella, Netty, et al.
Publicado: (2018)

The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021)

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
por: Russell, Beth, et al.
Publicado: (2018)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2021)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
por: Andersson, Joel, et al.
Publicado: (2022)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
por: Nordström, Tobias, et al.
Publicado: (2017)

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
por: Parker, Jonathan, et al.
Publicado: (2020)

How does COVID‐19 impact treatment decision‐making for clinicians in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2020)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Serial transperineal sector prostate biopsies: impact on long-term erectile dysfunction
por: Chong, James JY, et al.
Publicado: (2016)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

Factors that influence patients’ views on treatment decision-making in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2021)

Mortality following Hip Fracture in Men with Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
por: Bosco, Cecilia, et al.
Publicado: (2015)

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
por: Wong, Kathie, et al.
Publicado: (2023)

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
por: George, Gincy, et al.
Publicado: (2023)

Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
por: Rosenzweig, Barak, et al.
Publicado: (2022)

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
por: Khoshkar, Yashar, et al.
Publicado: (2021)

Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience
por: Bosco, Cecilia, et al.
Publicado: (2016)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Brief behavioural intervention, delivered as standard care, to support physical activity engagement in men with prostate cancer: a pilot study protocol
por: Fox, Louis, et al.
Publicado: (2018)

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)
por: Olsson, Henrik, et al.
Publicado: (2020)

Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
por: Nordström, Tobias, et al.
Publicado: (2021)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

Mobile Health Solutions for Prostate Cancer Diagnostics—A Systematic Review
por: Moghul, Masood, et al.
Publicado: (2023)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
por: Lin, E., et al.
Publicado: (2020)

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
por: Lin, E., et al.
Publicado: (2022)

PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2019)

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
por: Beckmann, Kerri, et al.
Publicado: (2021)

Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
por: Doluoglu, Omer Gokhan, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2kvfc760l9g7ajqk8d8pm3ki25